Pharsight

UNIVERSITY OF PENNSYLVANIA PENN PATENTS FACING OPPOSITIONS

Top patents of UNIVERSITY OF PENNSYLVANIA PENN facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3214091B1 03 Oct, 2018 Use Of Chimeric Antigen Receptor-Modified T Cells To Treat Cancer Dec, 2031 4
EP2872533B1 24 Apr, 2019 Methods Of Assessing The Suitability Of Transduced T Cells For Administration Jul, 2033 2
EP3549611B1 30 Jun, 2021 Switch Costimulatory Receptors Jul, 2032 1
EP3034093B1 13 Mar, 2019 Compositions And Methods Of Treating Tumors Mar, 2019 1